Clinical assay validation for SARS-CoV-2 sequencing using Swift Biosciences amplicon panel - News-Medical.Net
The current study used the guidelines of the FDA to validate the one-tube SARS-CoV-2 Swift Normalase Amplicon Panel Version 2.0 from Swift Biosciences.
The spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) over the whole world, causing successive waves of coronavirus disease 2019 (COVID-19), has led to intensive research int… [+7123 chars]
Read More
Other Stories in Health
- Internal appetite signals vary with socioeconomic background
- Brown rice may expose young children to unsafe arsenic levels, study finds
- Alarming! Heart attacks caused by sugar and not high cholesterol?
- Chemicals found in mattresses linked to cancer, brain damage: What is the alternative
- Doctors are urging BP patients to have 1 banana daily: 5 reasons to have this superfruit
- Digital lifestyle program cuts diabetes risk by 46% in prediabetics, study of 130k+ adults reveals
- Trial By Error: My Visits with Alem Matthees, 2025
- Healthy Egg Salad
- Can gut microbes help prevent Alzheimer’s?
.png)
